Swedbank AB »

Catalyst Pharmaceutical Partners shares owned by Swedbank AB

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Swedbank AB from 13F filings

Historical chart of Swedbank AB investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Swedbank AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Swedbank AB

Quarter filed Position value Share count Share price at filing
2025-09-30 $12M 616k 19.70
2025-06-30 $13M 616k 21.70
2025-03-31 $15M 616k 24.25

More positions owned by Swedbank AB

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Mastercard Incorporated Cl A (MA)
Citigroup Com New (C)
Arista Networks Com Shs (ANET)
Visa Com Cl A (V)
Analog Devices (ADI)

View all positions for Swedbank AB

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners